ExploreWatchlistsPricing
  1. US-listed companies
  2. Cyclo Therapeutics, Inc.
  3. Financials
  4. Operating income

Cyclo Therapeutics, Inc. (CYTH)

Market cap
$20.73M
P/E ratio
SummaryFinancials
Period EndOperating income (Million USD)YoY (%)
Dec 31, 2023-20+28.35%
Dec 31, 2022-16+9.32%
Dec 31, 2021-14+59.46%
Dec 31, 2020-9+18.78%
Dec 31, 2019-8+76.82%
Dec 31, 2018-4+11.02%
Dec 31, 2017-4-8.62%
Dec 31, 2016-4+74.75%
Dec 31, 2015-2+328.01%
Dec 31, 2014-1-267.03%
Dec 31, 20130+113.76%
Dec 31, 20120-312.08%
Dec 31, 2011-0

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat